vaccinesSubscribe to vaccines

Sanofi Pasteur (SP), the vaccine division of French integrated healthcare leader Sanofi, has signed an agreement with the University of Melbourne to co-fund proof-of-concept studies in relation to technologies developed by the University that can be used by the company to develop novel immune-boosting substances and vaccines against infectious diseases.

A discovery that has guided a life’s work has led to saving the lives of young children worldwide and inspired a revolution in public health.

Research from the University of Melbourne has shown that two different vaccine viruses- used simultaneously to control the same condition in chickens- have combined to produce new infectious viruses, prompting early response from Australia’s veterinary medicines regulator.